Introduction
Cardiovascular and renal conditions have been reported as secondary diseases in individuals suffering from type 2 diabetes and insulin resistance syndrome [32, 38] . A strong link between hyperuricemia, and the development of atherosclerosis, hypertension and insulin resistance has been reported, and uric acid has been described as a marker of both cardiovascular and renal disease risk [25, 38] . In vivo, uric acid is produced following oxidation of the aldehyde groups in xanthine or hypoxanthine by XO [68] . This reaction also generates superoxide radicals, which are responsible for the production of other compounds such as H 2 O 2 , hydroxyl and peroxyl radicals [87] . The generation of oxidants in endothelial cells can result in endothelial injury. Although uric acid is considered as an antioxidant in the early stages of atherosclerosis, it can become a pro-oxidant at a later stage in the progression of this condition. This change from anti-to prooxidant activity occurring in an oxidative environment depleted in antioxidants has been described as the urate redox shuttle [38] . Different synthetic XO inhibitors have been developed to control the formation of uric acid in vivo [68] . 1,5-Dihydro-4H-pyrazolo [3,4-d] pyrimidin-4-one (Allopurinol), an allosteric XO inhibitor, is used in the clinical management of hyperuricemia and gout [68] . Despite Allopurinol's potency, adverse side effects involving oxypurinol have been reported [87] . These include the development of fever, rash and Allopurinol hypersensitivity syndrome which can be fatal [5, 50, 68] . Therefore, the development of natural XO inhibitors has been proposed as a means of regulating XO activity in vivo. In order to reinforce endogenous antioxidant defense systems, supplementation of anti-oxidants through dietary intake has been proposed to counteract oxidative stress [33, 83] . Excess of dietary purine rich foods has been associated with an increased risk of gout [44] . However, Choi et al. [10] suggested that the consumption of moderate amounts of purine rich vegetables and proteins was not associated with an increased risk in gout. Changes in the diet have been suggested as a means of reducing the incidence of gout in humans. These include consumption of fruits, vegetables and low-fat dairy products and a decrease in meat, seafood and beer intake [44] . Different natural compounds, mainly plant extracts have been used for their XO inhibitory properties [50, 65, 79, 85, 90, 92] .
The most common natural XO inhibitors described in the literature are flavonoids, which have a relatively wide range of IC 50 values ranging between 0.75 and >40.00 M [87] .
Milk proteins and milk-derived peptides have been associated with health promoting and disease risk reducing activities, notably in the modulation of diverse conditions associated with the metabolic syndrome. These include the management of cardiovascular disease with angiotensin converting enzyme (ACE) inhibitory, antithrombotic, anti-inflammatory, mineral binding and anti-oxidant peptide activities [6, 12, 23, 49] . Milk proteins, peptide sequences encrypted within the primary structures of the milk proteins and amino acids have also been associated with the regulation of postprandial glycaemia and insulin secretion in normoglycaemic and type 2 diabetic subjects [24, 26, 56, 57, 61, 72] . Different studies have demonstrated the anti-oxidative role of milk proteins and peptides [19, 53, 70, 75, 83] . A fraction from human milk enriched in Trp has been identified for its high scavenging activity in vitro [84] . However, when evaluated in a Caco-2 cell culture, this fraction or Trp itself behaved as a pro-oxidant [20] . It has been reported that whey protein hydrolyzates can help decrease oxidative stress by their radical scavenging activity and by their ability to increase the production of antioxidant enzymes in vivo [40, 54, 70] .
Similarly, caseins and casein-derived peptides have been associated with radical-scavenging properties in vitro [8, 27, 47, 83] . Antioxidant activity of sodium casein hydrolyzates has been demonstrated in cell culture of human Jurkat cells with an increase in cellular catalase activity and different effects on GSH depending on the hydrolyzate studied [69] . Milk and dairy products have also been associated with the prevention of gout in humans as they can reduce serum urate [10, 11, 17] . Various fractions of milk have been tested in a cell culture model of THP-1 cells for their anti-inflammatory properties [16] . Glycomacropeptide was shown to inhibit Interleukin 1gene and protein expression of THP-1 cells and a milk fat extract (G600) could reduce the production of IL8 in response to monosodium urate monohydrate crystals [16] . These in vitro findings were confirmed in an in vivo mice model of gout where feeding with GMP and G600 resulted in an anti-inflammatory effect [16] . Recently, Dalbeth et al. [15] showed that ingestion of skim milk powder enriched with G600 and GMP could reduce the frequency of gout flares with patients.
As Trp shows structural similarities with Allopurinol, this amino acid appeared like an interesting candidate as a potential natural inhibitor of XO. The aim of this study was to explore the potential of Trp and Trp containing dipeptides to inhibit XO. Other non Trp containing dipeptides were also screened to their XO inhibitory potential. Milk proteins are a good source of Trp. Therefore, the enzymatic release of Trp and Trp containing peptides was carried out using different milk protein substrates and XO inhibition by milk protein hydrolyzates was also investigated.
Materials and methods

Reagents
The synthetic dipeptides Val-Trp, Trp-Val, Ala-Leu, Asp-Lys, Glu-Lys, Gly-Leu, Ser-Leu and Val-Ala were obtained from Bachem (Bubendorf, Switzerland) while Phe-Leu, His-Leu and Gly- obtained from a commercial supplier. Enzymatic hydrolysis of LF was carried out with two foodgrade commercial preparation of pancreatic (P -PTN 6.0S, Novozymes, Bagsvaerd, Denmark) and gastric (G -BC pepsin, Biocatalysts, Wales, UK) enzyme activities.
Methods
Hydrolysis of milk protein substrates
Two different food-grade gastro-intestinal enzymes: gastric enzyme preparation (G -BC pepsin) and a pancreatic enzyme preparation (P -PTN 6.0S) which have been identified for their ability to release Trp or Trp containing dipeptides were used to carry out hydrolysis of lactoferrin (LF).
The starting LF substrate was suspended at 10 % (w/w) on a protein basis in water and dispersed under agitation at 50C for 1 h using an overhead stirrer (Heidolph RZR 1, Germany). In the first instance, LF was hydrolyzed using PTN 6.0S with an enzyme to substrate ratio (E:S) of 2 % (w/w), where hydrolysis was conducted at 50°C, pH7.0 and hydrolyzate samples (PLF) were withdrawn at different time intervals (60, 120, 180 and 240 min). Secondly, LF was hydrolyzed at 50°C with BC pepsin for 240 min (GLF-240min) at an E:S of 3 % (w/w) , pH 3.0 followed by a 4 h hydrolysis with PTN 6.0S (E:S of 2 % (w/w), pH 7.0). Hydrolyzate samples (GPLF) were withdrawn at 60, 120, 180 and 240 min. The protein solutions were adjusted to pH 3.0 on hydrolysis with G and to pH 7.0 on hydrolysis with P using aqueous solutions of HCl 10.0 N or NaOH 2.0 N, respectively. A control sample was removed from the protein dispersion and maintained at 50°C for the duration of the hydrolysis reaction. Hydrolysis was carried out at a constant pH of 3.0 or 7.0 using a pH Stat (Titrando 843, Tiamo 1.4 Metrohm, Dublin, Ireland).
The enzyme was inactivated by heat treatment of the hydrolyzate samples at 90°C for 20 min.
Hydrolyzates were freeze-dried (FreeZone 18L, Labconco, Kansas City, U.S.A.) and stored at -20°C until further analysis.
Determination of the degree of hydrolysis
The degree of hydrolysis (DH) was determined using the TNBS (trinitrobenzenesulfonic acid) method following the procedure of Adler-Nissen [4] as modified by Spellman et al. [80] . 
Fractionation of LF hydrolyzates with activated carbon
Activated carbon was used to extract hydrophobic peptides [51] from the LF hydrolyzates (GLF240min). A custom-made solid-phase extraction (SPE) cartridge containing activated carbon was 7 produced by placing 10 g activated carbon in a 50 mL syringe (13 × 3 cm I.D. -Phenomenex, Cheshire, UK) fitted with frits at both ends to retain the activated carbon. The freeze-dried lactoferrin hydrolyzate (GLF-240min) was redispersed at 5% (w/v) in HPLC-grade water. A volume of 20 mL of this solution was slowly applied at the top of the syringe containing the activated carbon in order to allow adsorption of the peptides. The activated carbon was washed with water to remove any unbound material. Peptides were then eluted stepwise using 10, 20, 30, 40, 50, 60, 70 and 100 % (v/v) ACN as described by Herraiz and Casal [41] . The different fractions were dried using a solvent evaporator (Genevac, EZ-2 Plus, Genevac Ltd., Ipswich, UK).
Fluorescence detection of tryptophan
The detection of Trp and Trp-containing residues was carried out following Kema et al. [45] by 
Xanthine oxidase inhibition assay
The test samples (dipeptides and hydrolyzates) were dispersed in HPLC grade water at concentrations ranging from 1.25×10 -3 to 12.5 mg mL -1 . The XO inhibition assay was carried out following the method of Noro et al. [65] . 
Statistical analysis
Means comparison was carried out with a Student Newman-Keuls test using SPSS (version 9, SPSS Inc., Chicago, IL, USA) at a significance level P < 0.05. For the Lineweaver and Burke plots, experimental data were fitted by linear regression with SPSS.
Results
Xanthine oxidase inhibitory activity of dipeptides
The amino acid Trp presents structural similarities with Allopurinol, a potent XO inhibitor. For this reason, two Trp containing dipeptides (Val-Trp and its reverse peptide Trp-Val) were studied for their ability to inhibit XO. The XO inhibitory potential of ten other dipeptides was also studied. Of these twelve dipeptides, eight sequences (Table 1) could be released from bovine milk proteins following the hydrolytic action of different gastrointestinal enzymes (pepsin, trypsin and chymotrypsin activities) as determined using the Peptide Cutter program [21] . Of the twelve dipeptides, two (Val-Trp: 37.2 ± 2.2 % and Trp-Val: 36.7 ± 11.2 %) showed significant XO inhibitory properties (Table 1) . In order to better understand the origin of the inhibitory activity, the individual amino acids present in those two dipeptides were also evaluated for XO inhibitory activity ( and with Trp (0.014 ± 0.014 mM), Val-Trp (0.022 ± 0.009 mM) and Trp-Val (0.015 ± 0.017 mM) whereas significant differences were seen in the presence of Allopurinol (0.143 ± 0.031 mM).
These results suggest different types of inhibition with Allopurinol being a competitive inhibitor, whereas Trp, Val-Trp and Trp-Val behaved like non-competitive inhibitors of XO.
XO inhibition of the milk protein hydrolyzates and physicochemical characteristics of LF hydrolyzates
The release of Trp and Trp containing peptides from different milk protein substrates was carried out by enzymatic hydrolysis. Fifteen milk protein hydrolyzates generated with food-grade gastrointestinal enzyme preparations using three milk protein substrates (WPI, WPI Ret and NaCN) were initially evaluated. None of the 15 hydrolyzates tested inhibited XO (data not shown), suggesting that complex mixtures of milk proteins did not allow the generation of potent hydrolyzates which inhibit XO. A more targeted approach was therefore followed using LF, a Trp rich starting substrate, which was hydrolyzed with two food-grade enzyme preparations, i.e., with gastric (G) and/or pancreatic activities (P). In addition, the dipeptide Val-Trp can in theory be released from LF when hydrolyzed with gastrointestinal enzyme activities [21] . During the initial screen, all LF hydrolyzates showed similar XO inhibition values when tested at 12.5 mg mL -1 , apart from unhydrolyzed LF (Table 3) which had low XO inhibitory activity. The physicochemical characteristics of LF hydrolyzates were studied by determination of degree of hydrolysis ( Fig. 3) and by RP-UPLC (Fig. 4) . For the PLF series, the DH obtained on 1 h of hydrolysis was 21.4 ± 1.5 %, and increased to 26.3 ± 1.2 % after 4 h hydrolysis (Fig. 3) . In contrast, a relatively low DH (5.2 ± 0.3 %) was obtained when LF was hydrolyzed with the gastric enzyme G (GLF-240 min). DH significantly increased to 13.9 ± 1.3 % after 1 h hydrolysis for GLF-240 min with the pancreatic enzyme P. Surprisingly, the DH obtained with a combination of enzymes G and P (GPLF series) was lower than that of hydrolyzates generated with enzyme P alone (PLF series). In agreement with the relatively high DH, LF (Fig. 4a ) was substantially hydrolyzed in PLF-60 min (Fig. 4 b) . Very similar profiles were obtained for PLF-60 min (Fig. 4b) and PLF-240 min (Fig. 4c) . The peptide profiles of GLF-240 min hydrolyzate (Fig. 4d) and GPLF-240 min (Fig. 4e) were significantly different as expected due to differences in the cleavage specificity of the enzymes used.
XO inhibition by LF hydrolyzate fractions
Hydrolyzate GLF-240 min was fractionated using activated carbon in order to selectively retain hydrophobic peptides [2, 51] . Elution from activated carbon with ethanol has been carried out after extraction of peptides from a casein hydrolyzate [1] . In our study, different acetonitrile concentrations were used to elute peptides adsorbed on the activated carbon as described previously with different commercial SPE cartridges by Herraiz and Casal [41] . The 9 fractions eluted from the activated carbon cartridge, including the unbound fraction, were all assayed at 1.25 mg mL -1 for XO inhibitory activity (Table 4) 
Discussion
Consumption of low-fat dairy products has been associated with a reduced risk for developing gout [17, 44] . Ingestion of intact milk [18] or milk proteins [25] was shown to reduce serum urate concentration in an acute manner in healthy subjects. This was correlated with the low purine concentration of milk and an acute increase in the renal excretion of uric acid (uricosuric effect) and xanthine following the protein load [17, 25] . The acute uricosuric effect has been explained by multi-factorial parameters including a higher uric acid clearance with serum amino acid concentration increase and the concomitant clearance of urea and uric acid [25] . These different studies have demonstrated the positive effects of milk and particularly milk proteins on the regulation of uric acid in humans. Very little work has been carried out on the effect of milk protein hydrolyzates on the management of gout. Garell et al. [25] have shown that uric acid [58, 66] . The reverse peptide Trp-Val has also been described as an ACE inhibitor [67] and an anti-oxidant [31] . The amino acid Val did not show XO inhibition in contrast to Trp (Table 1 ). These results demonstrate that XO inhibition by the dipeptides was mainly due to the Trp residue. A Trp rich containing fraction from human mother's milk has previously been described for its antioxidant properties in vitro [84] . Certain amino acid structures have been correlated with high antioxidant properties. These include amino acids with sulfur residues (Cys and Met) and aromatic structures (Trp, Tyr, His and Phe) [19, 48, 60, 73, 75] . Phenol and indole groups in amino acids can act as potential hydrogen donors [70, 73, 75] . The radicals formed with phenol and indole amino acids are relatively stable, allowing inhibition of oxidation propagation [73] . Of the twelve dipeptides studied, only peptides containing a Trp residue displayed XO inhibitory activity (Table 1) . Phe and His containing dipeptides did not inhibit XO activity, suggesting that antioxidant activity may not directly correlate with XO inhibitory properties. Comparison of the molecular structure of Trp, Allopurinol and xanthine reveals many similarities between those 3 compounds all of which possess a C6 and a C5 ring structure. Inhibitors of XO have been found notably in the class of purine analogs eventhough a xanthine-like structure has not necessarily been correlated with high inhibitory activity [68] . Indeed, a non-purine competitive XO inhibitor such as FYX-051 has been reported as a more potent inhibitory drug than Allopurinol [59] .
Allopurinol was around 200 times more potent than Trp, Val-Trp or Trp-Val ( [67] . Similarly, Suetsuna and Chen [82] found that the antioxidant activity of dipeptides depended on the C or N terminal position of certain amino acid residues and they reported a stronger antioxidant activity for Trp-Lys compared to Lys-Trp. Our results showed no effect of the position of the Trp residue in the dipeptide on XO inhibition, suggesting that the N or C-terminal location of Trp does not affect its bioactivity. Amino acids have been reported to display a lower anti-oxidant activity compared to peptides as they have a lower radical scavenging activity [19] . In contrast, we found that Trp displayed a similar XO IC 50 inhibition has yet to be fully determined [79] No XO inhibition was observed with hydrolyzates of complex protein substrates such as WPI, WPI Ret and NaCN. This may be due to the fact that eventhough the bioactive sequences are present within these protein substrates, their abundance may be too low to observe any [12] and antioxidant agents [71] . Intact LF did not inhibit XO (Table 3) . In contrast to unhydrolyzed LF, LF hydrolyzates displayed a relatively high XO inhibition (> 80 % - Table 3 ).
Hydrolysis can affect bioactivity by releasing specific peptide sequences which were previously entrapped within the protein structure [19] . Free amino acids were quantified (Trp, Gln and Asn not determined) as per Mounier et al. [62] . Relatively low amounts of free amino acids were (Fig. 4) , suggesting that the peptide composition in both hydrolyzates was very similar. The DH values also showed that hydrolysis occurred to a limited extent between 1 and 4 h with a DH increase of 4.9 % within this time period (Fig. 3) .
Similarly, there was no significant difference (P ≥ 0.05) in XO inhibition between GLF-240 min and the GPLF hydrolyzate series (Table 3) . These results suggest that the bioactive peptides were released during the first stage of hydrolysis following hydrolysis with enzyme G. In this case, there was no benefit in combining the two enzymes G and P in order to improve bioactive peptide release. The RP profiles of GLF-240 min and GPLF-240 min samples (Fig. 4) differed. This is in agreement with the different cleavage specificity of the enzyme activities present in enzymes G and P. Despite differences in the peptide profile and the DH, no difference in XO inhibition was seen ( Table 3) . Combination of the enzyme preparations G and P mimics gastrointestinal digestion. Interestingly, the GLF-240 min hydrolyzate did not lose its XO inhibitory properties following the hydrolytic action of enzyme P, suggesting that the bioactive peptides may be of a relatively low molecular mass, which further supports our hypothesis that Trp and Trp containing dipeptides within these hydrolyzates may be responsible for XO inhibition.
Extrapolation of these in vitro results to in vivo may suggest that bioactive components in the GLF-240 min hydrolyzate would have the potential to survive gastro-intestinal digestion.
Comparison of the DH values for PLF and GPLF series revealed unexpected results, with DH values of the GPLF series being significantly lower than that of the PLF (Fig. 3) . Pre-digestion of LF with enzyme G should in theory have allowed a better access for enzyme P to the peptide bonds, resulting in higher DH values. A possible explanation for the lower DH values observed in the GPLF series may come from an inhibition of enzyme P by peptides present in the GLF-240 min hydrolyzate. Inhibition of lactic acid bacteria proteolytic enzymes by milk-derived peptides has been described previously [81] . Furthermore, sodium caseinate hydrolyzates have been shown to inhibit trypsin activity [34] .
Trp is characterized as a relatively hydrophobic amino acid, therefore, isolation of hydrophobic peptides from GLF-240 min hydrolyzate was attempted. It has been reported that activated carbon could selectively adsorb Trp and Phe amino acids or peptides containing these residues during debittering of milk protein hydrolyzates [13] . Activated carbon has been successfully used for the removal of Phe from food-protein hydrolyzates, notably to develop low-Phe content foods for phenylketonuric patients [55, 77] . Other uses of activated carbon have been to selectively prepare dipeptide mixtures with a high Fischer ratio (branched chain amino acids/ aromatic amino acids) with the low Fisher ratio peptides being adsorbed on the activated carbon [2] .
Activated carbon therefore appeared like an interesting adsorbent for the binding of hydrophobic components of the GLF-240 min hydrolyzate. The specific fluorescence detection of indole groups [45] was utilized in order to selectively detect Trp containing peptides in these fractions.
Binding of the GLF-240 min components to the activated carbon cartridge was achieved.
Surprisingly, the extraction procedure with activated carbon and ACN elution only allowed recovery of 28.0 % (w/w) of GLF-240 min hydrolyzate, suggesting strong binding on the activated carbon. Only 4 % (w/w) of the GLF-240 min hydrolyzate was found in the unbound fraction. In contrast with previous results where peptides from a casein hydrolyzate were extracted with activated carbon, a yield of nearly 30 % (at pH 6.5) was obtained in the unbound fraction [1] . These differences may arise from the particle size of the activated carbon used, with smaller particle size resulting in a larger surface area of the adsorbent and a higher adsorption capacity [78] . The different fractions collected displayed XO inhibition, with highest activity seen in the 30, 40 and 70 % ACN fraction (Table 4 ). The fact that bioactivity was found in several fractions suggests that the bioactivity arises from different compounds present in this hydrolyzate. This is further reinforced by the differences seen in the RP-HPLC profile of the fractions ( which was dose-dependent [20] . The pro-oxidant effect has been attributed to intracellular oxidation products coming from the interaction of oxidized Trp with other cellular components [20] . However the mechanism of Trp described in this paper is different as it involves inhibition of an enzyme and not scavenging of free-radicals. [61, 88] . In addition, amino acid uptake decreases with hydrolyzates containing higher peptide chain length [30] . Nevertheless, di-peptide uptake has been shown to be greater than that of amino acids [3] . XO is found in vivo in the plasma and in different tissues including the liver, gut, lung, kidney, brain and heart [68] . Therefore, bioactive components with XO inhibitory potential must be bioavailable to display their activity in vivo. Inhibition of XO by dipeptides is therefore highly relevant in this regard. In addition, Trp and Trp containing dipeptides are relatively hydrophobic in nature, which should allow them to permeate through the intestinal layer. Indeed, hydrophobic peptides have been associated with a high trans-epithelial permeation through a caco-2 cell monolayer [76] . Hydrolysis with a combination of gastric and pancreatic enzyme activities showed that the LF hydrolyzates were still bioactive, suggesting that these compounds may survive gastro-intestinal digestion and possibly reach the target organs in the body. concentrations. All fractions were tested at 1.25 mg mL -1 . Table 1 Compound 
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